Bluefin Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $481K | Buy |
+4,000
| New | +$462K | 0.31% | 47 |
|
|
2023
Q3 | – | Sell |
-3,700
| Closed | -$399K | – | 216 |
|
|
2023
Q2 | $427K | Buy |
+3,700
| New | +$420K | 0.08% | 64 |
|
|
2023
Q1 | – | Sell |
-29,300
| Closed | -$3.25M | – | 372 |
|
|
2022
Q4 | $3.25M | Buy |
29,300
+18,800
| +179% | +$1.92M | 0.48% | 38 |
|
|
2022
Q3 | $904K | Buy |
10,500
+8,200
| +357% | +$732K | 0.08% | 137 |
|
|
2022
Q2 | $213K | Sell |
2,300
-2,600
| -53% | -$230K | 0.02% | 291 |
|
|
2022
Q1 | $402K | Sell |
4,900
-14,928
| -75% | -$1.18M | 0.04% | 218 |
|
|
2021
Q4 | $1.52M | Buy |
19,828
+4,541
| +30% | +$362K | 0.11% | 155 |
|
|
2021
Q3 | $1.15M | Sell |
15,287
-39,834
| -72% | -$3.03M | 0.11% | 137 |
|
|
2021
Q2 | $4.29M | Buy |
55,121
+44,426
| +415% | +$3.3M | 0.27% | 68 |
|
|
2021
Q1 | $787K | Buy |
10,695
+2,725
| +34% | +$201K | 0.04% | 223 |
|
|
2020
Q4 | $622K | Buy |
+7,970
| New | +$610K | 0.04% | 248 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 182 |
|
|
2020
Q1 | – | Sell |
-121,908
| Closed | -$10.6M | – | 583 |
|
|
2019
Q4 | $10.6M | Buy |
121,908
+112,266
| +1,164% | +$9.22M | 0.7% | 33 |
|
|
2019
Q3 | $774K | Buy |
9,642
+1,782
| +23% | +$143K | 0.11% | 135 |
|
|
2019
Q2 | $629K | Buy |
+7,860
| New | +$602K | 0.09% | 126 |
|
|
2019
Q1 | – | Sell |
-9,746
| Closed | -$729K | – | 466 |
|
|
2018
Q4 | $711K | Buy |
9,746
+8,384
| +616% | +$592K | 0.07% | 132 |
|
|
2018
Q3 | $92K | Sell |
1,362
-74,218
| -98% | -$4.73M | 0.01% | 355 |
|
|
2018
Q2 | $4.38M | Buy |
+75,580
| New | +$4.26M | 0.33% | 58 |
|
|
2017
Q4 | – | Sell |
-20,090
| Closed | -$1.11M | – | 558 |
|
|
2017
Q3 | $1.23M | Buy |
20,090
+14,536
| +262% | +$881K | 0.14% | 130 |
|
|
2017
Q2 | $340K | Sell |
5,554
-6,729
| -55% | -$410K | 0.04% | 269 |
|
|
2017
Q1 | $745K | Buy |
12,283
+4,810
| +64% | +$292K | 0.1% | 149 |
|
|
2016
Q4 | $420K | Sell |
7,473
-5,317
| -42% | -$311K | 0.03% | 244 |
|
|
2016
Q3 | $762K | Sell |
12,790
-565
| -4% | -$33K | 0.03% | 153 |
|
|
2016
Q2 | $734K | Buy |
13,355
+9,328
| +232% | +$496K | 0.07% | 167 |
|
|
2016
Q1 | $203K | Sell |
4,027
-31,055
| -89% | -$1.52M | 0.02% | 299 |
|
|
2015
Q4 | $1.77M | Sell |
35,082
-3,505
| -9% | -$177K | 0.14% | 171 |
|
|
2015
Q3 | $1.82M | Sell |
38,587
-539
| -1% | -$28.6K | 0.11% | 134 |
|
|
2015
Q2 | $2.13M | Buy |
39,126
+20,097
| +106% | +$1.13M | 0.13% | 141 |
|
|
2015
Q1 | $1.04M | Sell |
19,029
-16,062
| -46% | -$909K | 0.1% | 174 |
|
|
2014
Q4 | $1.9M | Sell |
35,091
-27,695
| -44% | -$1.54M | 0.11% | 176 |
|
|
2014
Q3 | $3.55M | Sell |
62,786
-11,967
| -16% | -$672K | 0.19% | 121 |
|
|
2014
Q2 | $4.1M | Buy |
74,753
+44,745
| +149% | +$2.44M | 0.18% | 96 |
|
|
2014
Q1 | $1.6M | Sell |
30,008
-804
| -3% | -$41.6K | 0.1% | 161 |
|
|
2013
Q4 | $1.47M | Buy |
+30,812
| New | +$1.41M | 0.11% | 165 |
|
|
2013
Q3 | – | Sell |
-21,103
| Closed | -$900K | – | 505 |
|
|
2013
Q2 | $900K | Buy |
+21,103
| New | +$943K | 0.08% | 231 |
|
Other funds holding MRK
VCM
VPM
Bluefin Capital Management's MRK Position: Q1 2026 in Review
Bluefin Capital Management opened a new position in Merck (MRK) in Q1 2026: 4,000 shares worth $481K. The stake represents 0.31% of the portfolio and ranks #47 among its holdings. This is a return to the name: Bluefin Capital Management previously reported a position in MRK as recently as Q2 2023.
Bluefin Capital Management first reported a position in MRK in Q2 2013 and has held it in 34 quarters since. The position peaked at $10.6M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Bluefin Capital Management held 4,000 shares of Merck worth $481K as of Q1 2026.
- Merck was a new Bluefin Capital Management position in Q1 2026.
- Merck made up 0.31% of Bluefin Capital Management's portfolio in Q1 2026, its #47 holding.
- Bluefin Capital Management first reported a position in Merck in Q2 2013 and has held it in 34 quarters since.
- Bluefin Capital Management's Merck position peaked at $10.6M in Q4 2019.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.